% Expired Patents = 40.0

EPO Patents = 15

Trademarks = 7

Forward Citations = 507

Loading Chart...

11 inventors (with patents filed for the assignee):

Florian Von Der Mülbe (3 out of 20 patents)

Steve Pascolo (2 out of 24 patents)

Patrick Baumhof (2 out of 22 patents)

4. Ingmar Hoerr (2 out of 21 patents)

5. Thomas Kramps (1 out of 26 patents)

6. Thomas Schlake (1 out of 33 patents)

7. Thomas Ketterer (1 out of 25 patents)

8. Thorsten Mutzke (1 out of 22 patents)

9. Karl-Josef Kallen (1 out of 29 patents)

10. Ladislaus Reidel (1 out of 5 patents)

11. Söhnke Voss (1 out of 4 patents)

12. Andreas Thess (67 patents)

13. Jochen Probst (37 patents)

14. Mariola Fotin-Mleczek (27 patents)

15. Günther Jung (1 patent)

5 patents: Sort by Forward Citations

1. 9155788 - Application of mRNA for use as a therapeutic against tumour diseases (2015-10-13),

2. 8968746 - Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulation (2015-03-03),

3. 8703906 - Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids (2014-04-22),

4. 8383340 - Method for purifying RNA on a preparative scale by means of HPLC (2013-02-26),

5. 8217016 - Application of mRNA for use as a therapeutic agent for tumorous diseases (2012-07-10),

Curevac is a leading clinical-stage biopharmaceutical company focused on developing a new class of transformative medicines based on messenger RNA (mRNA). The company's innovative technology platform allows for the production of potent mRNA therapeutics for the treatment of a wide range of diseases, including infectious diseases and cancer.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

5 Patents

#25 in Tübingen

#6,097 in Germany

Tübingen, Germany

Curevac Gmbh